definiens: shall mean those efforts that are requiredto perform an obligation to develop or commercialize a Licensed Product in a sustained marmerconsistent with the those efforts that companIes of similar market ca italization as immunoGen, but in any event no less than ve un ed million do ars $ 500,000,000, which areICompetitive lin the market for onco 0 erapeullcs would typically devote to products of similar nature, market potential, profit potential or strategic value, in view of conditions prevailing at the time, and evaluated taking into account all relevant factors, including without limitation thecompetitiveness of the marketplace, the proprietary position of the product, the relative potentialsafety and efficacy of the product, the regulatory requirements involved in its development andcommercialization, and the seeking of Marketing Approval therefor, and other technical, legalscientific or medical factors . With respect to a particular Licensed Product, such efforts include, without limitation, the assignment of appropriate personnel to develop and commercialize suchproduct, the establishment of specific and meaningful goals regarding the development andcommercialization of such product and the allocation of sufficient resources to achieve suchgoals